JANSSEN VACCINES & PREVENTION BV - Netherlands 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 9
As coordinator: 0
As participant: 9
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 3.443.137 531.169 1
2022 0 234.530 0 1
2021 0 6.500.000 0 1
2019 0 9.553.988 265.620 2
2018 0 29.402.656 0 1
2017 0 20.050.441 25.000 1
2016 0 26.150.465 340.219 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
GLAXOSMITHKLINE BIOLOGICALS2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
ISTITUTO SUPERIORE DI SANITA2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
PFIZER LIMITED2
STATENS SERUM INSTITUT2
UNIVERSITE DE LAUSANNE2
UNIVERSITE JOSEPH FOURIER GRENOBLE 12
UNIVERSITY COLLEGE LONDON2
AARHUS UNIVERSITETSHOSPITAL AARHUS SYGEHUS1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGILENT TECHNOLOGIES FRANCE1
ARES GENETICS1
ASSOCIATION PACCI1
ASTRAZENECA1
BATAVIA BIOSCIENCES BV1
BIOCRATES LIFE SCIENCES1
BIOMERIEUX1
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GES M B H1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST1
COALITION FOR EPIDEMIC PREPAREDNESS INNOVATION1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DANMARKS TEKNISKE UNIVERSITET1
DEPARTMENT OF HEALTH1
ELSEVIER BV1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN VACCINE INITIATIVE EWIV1
EUROVACC FOUNDATION1
EXPRES2ION BIOTECHNOLOGIES APS1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FIT BIOTECH OY1
FOLKEHELSEINSTITUTTET1
FONDAZIONE PER L ISTITUTO DI RICERCA IN BIOMEDICINA1
FRED HUTCHINSON CANCER RESEARCH CENTER NON PROFIT CORPORATION1
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA1
GENOME RESEARCH1
HEINRICHPETTE INSTITUT LEIBNIZ INSTITUT FUER EXPERIMENTELLE VIROLOGIE1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG1
HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA1
IMAXIO1
INSERM TRANSFERT1
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT1
INSTITUT PASTEUR1
INSTITUTO DE SALUD CARLOS III1
INSTITUTO NACIONAL DE SAUDE1
INSTITUTO PASTEUR ITALIA FONDAZIONECENCI BOLOGNETTI1
INTERNATIONAL AIDS VACCINE INITIATIVE INC1
ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANIISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO1
JAMES COOK UNIVERSITY1
KAROLINSKA INSTITUTET1
LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS1
LIFE SCIENCE NETWORK GGMBH1
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER1
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN1
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV1
MEDICAL RESEARCH COUNCIL1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK SHARP & DOHME CORP1
MIHAJLOVIC JOVAN1
NATIONAL INSTITUTE FOR MEDICAL RESEARCH1
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU1
NOVAVAX AB1
OSIVAX SAS1
P95 CVBA1
PROGRAM FOR APPROPRIATE TECHNOLOGYIN HEALTH1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
SANOFI PASTEUR1
SANOFIAVENTIS1
SERVICIO ANDALUZ DE SALUD1
SORBONNE UNIVERSITE1
SOVALACC BV1
STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER1
STICHTING INTERNATIONAL AIDS VACCINE INITIATIVE THE NETHERLANDS1
STICHTING KATHOLIEKE UNIVERSITEIT1
STIMUNITY SAS1
SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG1
THE FEDERAL STATE SCIENTIFIC INSTITUTION SAINTPETERSBURG SCIENTIFIC RESEARCH PASTEUR INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY1
THE GENERAL HOSPITAL CORPORATION1
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN1
THE UNIVERSITY OF EDINBURGH1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF TUEBINGEN1
UGANDA NATIONAL HEALTH RESEARCH ORGANISATION1
UMEA UNIVERSITET1
UNITED KINGDOM RESEARCH AND INNOVATION1
UNIVERSITA DEGLI STUDI DI FERRARA1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITA DEGLI STUDI DI VERONA1
UNIVERSITAET BERN1

Constancy:

Total number of partners: 135
Partner loyalty:
Frequent Partner: (> 2 projects): 11
Rare Partner: 124
Frequent / Rare Partner Ratio: 0.09

Project overview:

Start dateProjectacronymrolefundingpartners
2023-05-01Intelligent design of adenovirus vectors (iAds) iAdsparticipant3.443.1378
2022-06-01Experimental vaccinology, revealing unnatural signatures of protection by repeat controlled human schistosome infection. ReCHISVacparticipant234.5302
2021-11-01Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance PrIMAVeRaparticipant6.500.00019
2019-05-01INnate-ImmunomeTabolIsm as Antiviral TargEt INITIATEparticipant4.054.10614
2019-01-01Vaccines and Infectious Diseases in the Ageing PopuLation VITALparticipant5.499.88224
2018-06-01Bringing a prophylactic Ebola vaccine to licensure EBOVAC3participant29.402.6567
2017-01-01Optimizing a deployable high efficacy malaria vaccine OptiMalVaxparticipant20.050.44118
2016-05-01Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology EDGEparticipant3.961.9439
2016-01-01European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates EHVAparticipant22.188.52243